Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer

First-line chemotherapy for patients with metastatic pancreatic cancer (MPC) includes gemcitabine plus nab-paclitaxel (GnP) and FOLFIRINOX (FFX). However, the efficacy of second-line chemotherapy and the role of combination chemotherapy in clinical practice is still unknown. Data was gathered from 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukahori, Masaru, Okabe, Yoshinobu, Shimokawa, Mototsugu, Otsuka, Taiga, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Komori, Azusa, Otsu, Satoshi, Arima, Shiho, Makiyama, Akitaka, Taguchi, Hiroki, Honda, Takuya, Ushijima, Tomoyuki, Miwa, Keisuke, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Mizuta, Toshihiko, Mitsugi, Kenji, Shirakawa, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632451/
https://www.ncbi.nlm.nih.gov/pubmed/37938630
http://dx.doi.org/10.1038/s41598-023-46924-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632451/
https://www.ncbi.nlm.nih.gov/pubmed/37938630
http://dx.doi.org/10.1038/s41598-023-46924-0

Ejemplares similares